Kennedy Krieger Institute
Baltimore, Maryland, 21205, United States
Location contact
Emily J Amsden, BS
CONTACT
Rachel K Peterson, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07558473
The goal of this study is to learn if an online computerized training program improves processing speed, attention, and working memory in children with a primary brain tumor during and after active cancer treatment. The main questions it aims to answer are:
1. Is the cognitive intervention feasible to administer to children with brain tumors during and after cancer treatment?, 2. Is the cognitive intervention acceptable to children and caregivers?, and 3. Does the cognitive intervention improve neuropsychological functioning?
There is no comparison group for this study.
Participants will:
1. Complete an online computerized cognitive training program for approximately 15 minutes per day, 5 days a week, for 8 weeks; 2. Have weekly check-ins with the cognitive coach, 3. Complete a survey at the end of the cognitive training program, and 4. Complete pre- and post- neuropsychological testing.
Trial opening soon.
Get Notified5 year–25 year
All sexes
Interventional
Not applicable
Baltimore, Maryland, 21205, United States
Emily J Amsden, BS
CONTACT
Rachel K Peterson, PhD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This online cognitive training program aims to improve processing speed through computerized cognitive exercises. Participants will complete approximately 15 minutes of training, 5 days per week for 8 weeks. Weekly check-ins with a cognitive coach will assist with engagement and problem solve any barriers.
Time frame: Up to 5 years after diagnosis.
Study enrollment rate.
Time frame: 8 weeks
Number of participants who complete the computerized brain training program.
Time frame: Through study completion, an average of 8 weeks.
Number of levels completed in the cognitive training program. Qualitative feedback regarding barriers and facilitators to engagement will also we collected to provide descriptive context.
Time frame: 8 weeks
Total time spent completing the cognitive training program exercises.
Time frame: At the end of the 8-week intervention.
Parent and self-reported acceptability measured using a Likert-scale questionnaire administered at the end of the intervention. Mean total score will be reported. Qualitative feedback regarding participant experience will also be collected to provide descriptive context.
Time frame: Prior to the intervention, immediately following intervention, and 6 months after intervention completion.
Changes in neuropsychological functioning, as measured by the train-to-task activity.
Time frame: Prior to the intervention, immediately following intervention, and 6 months after intervention completion.
Changes in processing speed as measured by the NIH toolbox.
Time frame: Prior to the intervention, immediately following intervention, and 6 months after intervention completion.
Changes in attention as measured by the NIH toolbox.
Time frame: Prior to the intervention, immediately following intervention, and 6 months after intervention completion.
Changes in working memory as measured by the NIH toolbox.
Contact information is provided by the study sponsor or research team.
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06905587
Brain Diseases, Brain Neoplasms
Aalborg, Denmark
View Trial DetailsNCT03086421
Behavior, Brain Diseases
Memphis, Tennessee, United States
View Trial DetailsNCT07390539
Atypical Teratoid/Rhabdoid Tumor, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT06093165
Brain Diseases, Brain Neoplasms
View Trial Details